Oncogenic Signalling of PEAK2 Pseudokinase in Colon Cancer
Authors:
Open Access
Abstract
The PEAK family pseudokinases are essential components of tyrosine kinase (TK) pathways that regulate cell growth and adhesion; however, their role in human cancer remains unclear. Here, we report an oncogenic activity of the pseudokinase PEAK2 in colorectal cancer (CRC). Notably, high PRAG1 expression, which encodes PEAK2, was associated with a bad prognosis in CRC patients. Functionally, PEAK2 depletion reduced CRC cell growth and invasion in vitro, while its overexpression increased these transforming effects. PEAK2 depletion also reduced CRC development in nude mice. Mechanistically, PEAK2 expression induced cellular protein tyrosine phosphorylation, despite its catalytic inactivity. Phosphoproteomic analysis identified regulators of cell adhesion and F-actin dynamics as PEAK2 targets. Additionally, PEAK2 was identified as a novel ABL TK activator. In line with this, PEAK2 expression localized at focal adhesions of CRC cells and induced ABL-dependent formation of actin-rich plasma membrane protrusions filopodia that function to drive cell invasion. Interestingly, all these PEAK2 transforming activities were regulated by its main phosphorylation site, Tyr413, which implicates the SRC oncogene. Thus, our results uncover a protumoural function of PEAK2 in CRC and suggest that its deregulation affects adhesive properties of CRC cells to enable cancer progression.Keywords
Funding Information
- Institut National Du Cancer (PLBIO-2011-150, Equipe Labellisée 2020, INCa-DGOS-Inserm 6045)
- La ligue contre le cancer (PLBIO-2011-150, Equipe Labellisée 2020, INCa-DGOS-Inserm 6045)
- FRM (PLBIO-2011-150, Equipe Labellisée 2020, INCa-DGOS-Inserm 6045)
- Institut National Du Cancer (PLBIO-2011-150, Equipe Labellisée 2020, INCa-DGOS-Inserm 6045)
- CNRS (PLBIO-2011-150, Equipe Labellisée 2020, INCa-DGOS-Inserm 6045)
- University of Montpellier (PLBIO-2011-150, Equipe Labellisée 2020, INCa-DGOS-Inserm 6045)
This publication has 57 references indexed in Scilit:
- Gene Expression Classification of Colon Cancer into Molecular Subtypes: Characterization, Validation, and Prognostic ValuePLOS Medicine, 2013
- The Growing Arsenal of ATP-Competitive and Allosteric Inhibitors of BCR–ABLCancer Research, 2012
- SH3 Domain Tyrosine Phosphorylation – Sites, Role and EvolutionPLOS ONE, 2012
- Mammalian Pragmin regulates Src family kinases via the Glu-Pro-Ile-Tyr-Ala (EPIYA) motif that is exploited by bacterial effectorsProceedings of the National Academy of Sciences, 2011
- The proximal signaling network of the BCR-ABL1 oncogene shows a modular organizationOncogene, 2010
- Pseudopodium-enriched atypical kinase 1 regulates the cytoskeleton and cancer progressionProceedings of the National Academy of Sciences, 2010
- Src family tyrosine kinases-driven colon cancer cell invasion is induced by Csk membrane delocalizationOncogene, 2009
- The tyrosine kinase Abl is required for Src-transforming activity in mouse fibroblasts and human breast cancer cellsOncogene, 2007
- Pragmin, a Novel Effector of Rnd2 GTPase, Stimulates RhoA ActivityJournal of Biological Chemistry, 2006
- A specific function for phosphatidylinositol 3-kinase α (p85α-p110α) in cell survival and for phosphatidylinositol 3-kinase β (p85α-p110β) in de novo DNA synthesis of human colon carcinoma cellsOncogene, 2000